INIS
acetic acid
8%
apoptosis
5%
attitudes
9%
biopsy
8%
cancer
100%
carcinomas
16%
cell cultures
5%
chemotherapy
16%
communities
9%
comparative evaluations
10%
control
5%
data
12%
diseases
16%
females
11%
fluids
5%
gynecology
6%
hospitals
18%
humans
13%
indonesia
33%
information systems
5%
inspection
8%
levels
13%
lymphocytes
7%
management
11%
metastases
13%
neoplasms
7%
obstetrics
5%
ovaries
51%
patients
78%
radiotherapy
9%
reviews
15%
risks
12%
safety
9%
screening
9%
stem cells
11%
surgery
24%
therapy
11%
tissues
9%
tumors
20%
variations
6%
women
28%
Keyphrases
Advanced Ovarian Cancer
14%
Advanced Stage
7%
Cancer Registration
6%
Cancer Registry
7%
Cancer Stem Cells
10%
Cervical Cancer
30%
Cervical Cancer Patients
10%
Cervical Cancer Screening
5%
Chemotherapy
16%
Complete Response
5%
Disease-free Survival
5%
General Hospital
6%
Gynecological Cancer
13%
Histopathological Examination
5%
Human Papillomavirus Vaccine
5%
Immune Checkpoint Inhibitors
9%
Indonesia
29%
Indonesian
18%
Jakarta
19%
Knowledge Attitude
9%
Knowledge Practices
9%
Median Survival
5%
Meta-analysis of Randomized Controlled Trials
9%
Mucinous
6%
Obstetrics and Gynaecology
5%
Odds Ratio
8%
Ovarian Cancer
15%
Ovarian Cancer Patients
8%
Papillomavirus Infections
9%
Patient-reported Outcomes
9%
Precancerous Lesions
5%
Radiotherapy
9%
Risk Factors
6%
Safety Self-efficacy
9%
Society of Gynecologic Oncology
6%
Socio-demographic Profile
5%
Surgical Staging
7%
Systematic Meta-analysis
9%
Tumor
8%
Tumor Size
5%
Urban Community
9%
Visual Inspection with Acetic Acid
9%
Vulvar
6%
Women of Reproductive Age
5%
Young Female
5%
Medicine and Dentistry
Acetic Acid
9%
Biopsy Technique
6%
Cancer Registry
10%
Cancer Stem Cell
12%
Cell Culture
5%
Cervical Cancer
19%
Cervical Cancer Screening
5%
Cervix
6%
Cross Sectional Study
5%
Cytoreductive Surgery
6%
Debulking Surgery
6%
Disease Free Survival
5%
Diseases
6%
Female Genital Tract Cancer
12%
Gynecological Oncology
8%
Histopathology
6%
Immune Checkpoint Inhibitor
9%
Krukenberg Tumor
18%
Laparotomy
7%
Malignant Neoplasm
11%
Meta-Analysis
9%
Metastatic Carcinoma
13%
Neoplasm
16%
Ovarian Cancer
30%
Ovarian Tumor
8%
Patient-Reported Outcome
9%
Precancerous Condition
5%
Prevalence
6%
Radiation Therapy
9%
Randomized Controlled Trial
9%
Recurrent Disease
6%
Squamous Cell Carcinoma
7%
Surgery
11%
Systematic Review
9%
Uterine Cancer
6%
Wart Virus
5%